Equities

Qianhai Health Holdings Ltd

Qianhai Health Holdings Ltd

Actions
TechnologyTechnology Hardware and Equipment
  • Price (HKD)0.32
  • Today's Change0.00 / 0.00%
  • Shares traded160.75k
  • 1 Year change-15.79%
  • Beta0.2843
Data delayed at least 15 minutes, as of Nov 12 2024 07:13 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in HKDIncome statement in HKDView more

Year on year Qianhai Health Holdings Ltd has grown net income from a loss of -233.70m to a smaller loss of -52.71m despite declining revenues.
Gross margin13.69%
Net profit margin8.07%
Operating margin8.08%
Return on assets15.90%
Return on equity20.70%
Return on investment20.69%
More ▼

Cash flow in HKDView more

In 2023, Qianhai Health Holdings Ltd increased its cash reserves by 1,089.10%, or 17.88m. Cash Flow from Investing totalled 17.77m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 857.00k in cash from operations while cash used for financing totalled 743.00k.
Cash flow per share0.4526
Price/Cash flow per share0.7071
Book value per share2.36
Tangible book value per share2.36
More ▼

Balance sheet in HKDView more

Qianhai Health Holdings Ltd uses little debt in its capital structure as supported by a debt to capital ratio of 0.03%.
Current ratio3.99
Quick ratio0.9943
Total debt/total equity0.0003
Total debt/total capital0.0003
More ▼

Growth rates in HKD

Year on year, growth in earnings per share excluding extraordinary items increased 77.45%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
120.51
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.